1. Executive Summary
1.1. Global Market Outlook
1.2. Global Phospholipids Market Analysis by Segments and Region
1.3. Competition Blueprint
1.4. Demand Side Trends
1.5. Supply Side Trends
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation/Development Trends
4. Key Success Factors
4.1. Key Success Factors
4.2. Phospholipids Production Overview
4.3. Production Capacity Analysis by Key countries
4.4. Strategic Promotional Strategies
5. Global Phospholipids Demand Analysis 2017-2021 and Forecast, 2022-2032
5.1. Historical Market Volume (Tons) Analysis, 2017-2021
5.2. Current and Future Market Volume (Tons) Projections, 2022-2032
5.3. Y-o-Y Growth Trend Analysis
6. Global Phospholipids - Pricing Analysis
6.1.1. Regional Pricing Analysis By Product Type
6.1.2. Global Average Pricing Analysis Benchmark
6.1.3. Factors Influencing Price
7. Global Phospholipids Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Increasing Global Population
8.1.2. Inflation Rate of Emerging Countries
8.1.3. Increasing SMEs in the cosmetics sector
8.1.4. Per Capita Expenditure on Personal Care Products
8.1.5. Growth of Functional Foods Industry
8.1.6. Merger and Acquisition Taken by Industry Players
8.1.7. Change in Promotional Strategies and Marketing Efforts
8.1.8. Research and Development Expenditure
8.1.9. Clean Label and Ingredient Transparency
8.1.10. Increasing Urban Population
8.2. Forecast Factors - Relevance & Impact
8.2.1. Historic Growth Rate of Companies
8.2.2. Impact of Regulations
8.2.3. Growth of Functional Foods Industry
8.2.4. Increasing Urban Population
8.2.5. Inflation Rate of Emerging Countries
8.2.6. Increasing SMEs in the cosmetics sector
8.2.7. Per Capita Expenditure on Personal Care Products
8.2.8. Research and Development Expenditure
8.2.9. Clean Label and Ingredient Transparency
8.3. Value Chain
8.3.1. List of Raw Material Suppliers
8.3.2. List of Manufacturers
8.3.3. List of End Users
8.3.4. End-User/Customer Mapping
8.3.4.1. Indicative Consumption Volume
8.3.4.2. Application
8.3.4.3. Location
8.3.5. Operating Margins Analysis
8.4. Impact of COVID – 19 Crisis
8.4.1. Current Statistics
8.4.2. Short-Mid-Long Term Outlook
8.4.3. Likely Rebound
8.5. Market Dynamics
8.5.1. Drivers
8.5.2. Restraints
8.5.3. Opportunity Analysis
8.6. Key Regulations and Certifications
9. Global Phospholipids Analysis 2017-2021 and Forecast 2022-2032, by Product Type
9.1. Introduction/Key Findings
9.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2017 - 2021
9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2022 - 2032
9.3.1. Natural Phospholipids
9.3.1.1. Soybean
9.3.1.2. Sunflower
9.3.1.3. Rapeseed
9.3.1.4. Egg
9.3.1.5. Others (Milk, Peanuts, etc.)
9.3.2. Synthetic Phospholipids
9.4. Market Attractiveness Analysis, By Product Type
10. Global Phospholipids Analysis 2017-2021 and Forecast 2022-2032, by Function
10.1. Introduction/Key Findings
10.2. Historical Market Size (US$ Mn) and Volume Analysis By Function, 2017 - 2021
10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Function, 2022 - 2032
10.3.1. Emulsifiers
10.3.2. Texturizers
10.3.3. Stabilizers
10.3.4. Binding Agents
10.3.5. Releasing Agents
10.4. Market Attractiveness Analysis By Function
11. Global Phospholipids Analysis 2017-2021 and Forecast 2022-2032, By Application
11.1. Introduction/Key Findings
11.2. Historical Market Size (US$ Mn) and Volume Analysis By Application, 2017 - 2021
11.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Application, 2022 - 2032
11.3.1. Cosmetics
11.3.1.1. Skin Care
11.3.1.2. Hair Care
11.3.2. Pharmaceuticals
11.3.3. Nutraceuticals
11.4. Market Attractiveness Analysis By Application
12. Global Phospholipids Analysis 2017-2021 and Forecast 2022-2032, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2017 - 2021
12.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2022 - 2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia & Pacific
12.3.6. Middle East & Africa
12.4. Market Attractiveness Analysis By Region
13. North America Phospholipids Analysis 2017-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
13.4.1. By Product Type
13.4.2. By Function
13.4.3. By Application
13.4.4. By Country
13.4.4.1. U.S.
13.4.4.2. Canada
13.5. Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By Function
13.5.3. By Application
13.5.4. By Country
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints Impact Analysis
14. Latin America Phospholipids Analysis 2017-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
14.4.1. By Product Type
14.4.2. By Function
14.4.3. By Application
14.4.4. By Country
14.4.4.1. Brazil
14.4.4.2. Mexico
14.4.4.3. Rest of Latin America
14.5. Market Attractiveness Analysis
14.5.1. By Product Type
14.5.2. By Function
14.5.3. By Application
14.5.4. By Country
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints Impact Analysis
15. Europe Phospholipids Analysis 2017-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
15.4.1. By Product Type
15.4.2. By Function
15.4.3. By Application
15.4.4. By Country
15.4.4.1. Germany
15.4.4.2. Italy
15.4.4.3. France
15.4.4.4. U.K.
15.4.4.5. Spain
15.4.4.6. BENELUX
15.4.4.7. Russia
15.4.4.8. Rest of Europe
15.5. Market Attractiveness Analysis
15.5.1. By Product Type
15.5.2. By Function
15.5.3. By Application
15.5.4. By Country
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints Impact Analysis
16. South Asia & Pacific Phospholipids Analysis 2017-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
16.4.1. By Product Type
16.4.2. By Function
16.4.3. By Application
16.4.4. By Country
16.4.4.1. India
16.4.4.2. ASEAN
16.4.4.3. Oceania
16.4.4.4. Rest of South Asia & Pacific
16.5. Market Attractiveness Analysis
16.5.1. By Product Type
16.5.2. By Function
16.5.3. By Application
16.5.4. By Country
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints Impact Analysis
17. East Asia Phospholipids Analysis 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
17.4.1. By Product Type
17.4.2. By Function
17.4.3. By Application
17.4.4. By Country
17.4.4.1. China
17.4.4.2. Japan
17.4.4.3. South Korea
17.5. Market Attractiveness Analysis
17.5.1. By Product Type
17.5.2. By Function
17.5.3. By Application
17.5.4. By Country
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints Impact Analysis
18. Oceania Phospholipids Analysis 2017-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
18.4.1. By Product Type
18.4.2. By Function
18.4.3. By Application
18.4.4. By Country
18.4.4.1. Australia
18.4.4.2. New Zealand
18.5. Market Attractiveness Analysis
18.5.1. By Product Type
18.5.2. By Function
18.5.3. By Application
18.5.4. By Country
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints Impact Analysis
19. Middle East and Africa Phospholipids Analysis 2017-2021 and Forecast 2022-2032
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
19.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
19.4.1. By Product Type
19.4.2. By Function
19.4.3. By Application
19.4.4. By Country
19.4.4.1. GCC Countries
19.4.4.2. Turkey
19.4.4.3. Northern Africa
19.4.4.4. South Africa
19.4.4.5. Rest of Middle East and Africa
19.5. Market Attractiveness Analysis
19.5.1. By Product Type
19.5.2. By Function
19.5.3. By Application
19.5.4. By Country
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints Impact Analysis
20. Emerging Countries Phospholipids Market Analysis
20.1. U.S. Phospholipids Analysis
20.1.1. By Product Type
20.1.2. By Function
20.1.3. By Application
20.2. Canada Phospholipids Analysis
20.2.1. By Product Type
20.2.2. By Function
20.2.3. By Application
20.3. Mexico Phospholipids Analysis
20.3.1. By Product Type
20.3.2. By Function
20.3.3. By Application
20.4. Brazil Phospholipids Analysis
20.4.1. By Product Type
20.4.2. By Function
20.4.3. By Application
20.5. Germany Phospholipids Analysis
20.5.1. By Product Type
20.5.2. By Function
20.5.3. By Application
20.6. Italy Phospholipids Analysis
20.6.1. By Product Type
20.6.2. By Function
20.6.3. By Application
20.7. France Phospholipids Analysis
20.7.1. By Product Type
20.7.2. By Function
20.7.3. By Application
20.8. U.K. Phospholipids Analysis
20.8.1. By Product Type
20.8.2. By Function
20.8.3. By Application
20.9. Spain Phospholipids Analysis
20.9.1. By Product Type
20.9.2. By Function
20.9.3. By Application
20.10. Russia Phospholipids Analysis
20.10.1. By Product Type
20.10.2. By Function
20.10.3. By Application
20.11. China Phospholipids Analysis
20.11.1. By Product Type
20.11.2. By Function
20.11.3. By Application
20.12. Japan Phospholipids Analysis
20.12.1. By Product Type
20.12.2. By Function
20.12.3. By Application
20.13. S. Korea Phospholipids Analysis
20.13.1. By Product Type
20.13.2. By Function
20.13.3. By Application
20.14. India Phospholipids Analysis
20.14.1. By Product Type
20.14.2. By Function
20.14.3. By Application
20.15. ASEAN Phospholipids Analysis
20.15.1. By Product Type
20.15.2. By Function
20.15.3. By Application
20.16. Oceania Phospholipids Analysis
20.16.1. By Product Type
20.16.2. By Function
20.16.3. By Application
20.17. Turkey Phospholipids Analysis
20.17.1. By Product Type
20.17.2. By Function
20.17.3. By Application
20.18. South Africa Phospholipids Analysis
20.18.1. By Product Type
20.18.2. By Function
20.18.3. By Application
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies [Phospholipids]
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
21.3.1. By Regional footprint of Players
21.3.2. By Product footprint of Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Company Deep Dive
22.3.1. Avanti Polar Lipids Inc.
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Key Financials
22.3.1.4. Sales Footprint
22.3.1.5. Strategy Overview
22.3.2. Bunge Ltd.
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Key Financials
22.3.2.4. Sales Footprint
22.3.2.5. Strategy Overview
22.3.3. Cargill, Inc.
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Key Financials
22.3.3.4. Sales Footprint
22.3.3.5. Strategy Overview
22.3.4. Lecico GmbH
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Key Financials
22.3.4.4. Sales Footprint
22.3.4.5. Strategy Overview
22.3.5. Lipoid GmbH
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Key Financials
22.3.5.4. Sales Footprint
22.3.5.5. Strategy Overview
22.3.6. VAV Life Sciences Pvt. Ltd.
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Key Financials
22.3.6.4. Sales Footprint
22.3.6.5. Strategy Overview
22.3.7. Matreya, LLC
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Key Financials
22.3.7.4. Sales Footprint
22.3.7.5. Strategy Overview
22.3.8. NOF CORPORATION
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Key Financials
22.3.8.4. Sales Footprint
22.3.8.5. Strategy Overview
22.3.9. Fonterra Co-Operative Group Limited
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Key Financials
22.3.9.4. Sales Footprint
22.3.9.5. Strategy Overview
22.3.10. Larodan AB
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Key Financials
22.3.10.4. Sales Footprint
22.3.10.5. Strategy Overview
22.3.11. Wuxi Accobio Biotech Inc.
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Key Financials
22.3.11.4. Sales Footprint
22.3.11.5. Strategy Overview
22.3.12. Abhay Nutrition Pvt. Ltd.
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Key Financials
22.3.12.4. Sales Footprint
22.3.12.5. Strategy Overview
22.3.13. Sonic Biochem
22.3.13.1. Overview
22.3.13.2. Product Portfolio
22.3.13.3. Key Financials
22.3.13.4. Sales Footprint
22.3.13.5. Strategy Overview
22.3.14. CordenPharma International
22.3.14.1. Overview
22.3.14.2. Product Portfolio
22.3.14.3. Key Financials
22.3.14.4. Sales Footprint
22.3.14.5. Strategy Overview
22.3.15. Nippon Fine Chemical Co., Ltd.
22.3.15.1. Overview
22.3.15.2. Product Portfolio
22.3.15.3. Key Financials
22.3.15.4. Sales Footprint
22.3.15.5. Strategy Overview
22.3.16. Kewpie Corporation
22.3.16.1. Overview
22.3.16.2. Product Portfolio
22.3.16.3. Key Financials
22.3.16.4. Sales Footprint
22.3.16.5. Strategy Overview
22.3.17. Soja Protein a.d.
22.3.17.1. Overview
22.3.17.2. Product Portfolio
22.3.17.3. Key Financials
22.3.17.4. Sales Footprint
22.3.17.5. Strategy Overview
22.3.18. Stern-Wywiol Gruppe
22.3.18.1. Overview
22.3.18.2. Product Portfolio
22.3.18.3. Key Financials
22.3.18.4. Sales Footprint
22.3.18.5. Strategy Overview
Note: List of companies is not exhaustive in nature. It is subject to further refinement and augmentation during course of research.
